(Q44675361)

5 December 2017

Patterns of early recurrence after sentinel lymph node biopsy for melanoma (English)

1 reference

5 December 2017

0 references

0 references

8

Kelly M McMasters

1 reference

5 December 2017

Celia Chao

1

1 reference

5 December 2017

Sandra L Wong

2

1 reference

5 December 2017

Merrick I Ross

3

1 reference

5 December 2017

Douglas S Reintgen

4

1 reference

5 December 2017

R Dirk Noyes

5

1 reference

5 December 2017

Patricia B Cerrito

6

1 reference

5 December 2017

Michael J Edwards

7

1 reference

5 December 2017

Sunbelt Melanoma Trial Group

9

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

The American Journal of Surgery

5 December 2017

1 reference

5 December 2017

184

1 reference

5 December 2017

520-4; discussion 525

1 reference

5 December 2017

6

1 reference

Technical details of intraoperative lymphatic mapping for early stage melanoma

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

The orderly progression of melanoma nodal metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

Recent advances in melanoma staging and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

Risk factors for nodal recurrence after lymphadenectomy for melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

Outcome of patients with melanoma and histologically negative sentinel lymph nodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

Sentinel lymph node biopsy for melanoma: experience with 234 consecutive procedures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

Reliability of sentinel lymph node biopsy for staging melanoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

Sentinel lymph node biopsy for melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

Molecular staging of malignant melanoma: correlation with clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

A new American Joint Committee on Cancer staging system for cutaneous melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

Regional nodal basin control is not compromised by previous sentinel lymph node biopsy in patients with melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2901102-9

10.1016/S0002-9610(02)01102-9

7 January 2021

Identifiers

DOI

1 reference

5 December 2017

1 reference